U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07110831) titled 'Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria' on May 15.
Brief Summary: The goal of this clinical trial is to find out the usefulness and well-being of people when drugs for treating depression (fluoxetine) and HIV (dolutegravir) are used together. It will also learn about how safe it is to take fluoxetine and dolutegravir together by the people living with HIV (PLWH).
The main questions it aims to answer are:
* Does fluoxetine (antidepressant) make participants taking anti-HIV (dolutegravir) feel better?
* What medical problems do participants have when taking fluoxetine and d...